Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
ITL and Oncascan Developing Instrument for New Cancer Test
Thursday, June 18, 2015
Integrated Technologies Limited has signed a development contract with
diagnostics start-up Oncascan Limited for a new cancer test.
Applied Biosystems New TaqMan Advanced miRNA Assays
Wednesday, June 17, 2015
These new miRNA assays provide universal reverse transcription designed for superior sensitivity in miRNA analysis by real-time PCR.
Merck Millipore Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
Tuesday, June 16, 2015
Services accelerate time to the clinic by delivering high quality, high expressing cell lines.
Abcam Launches Multiplex miRNA Profiling Assays
Wednesday, June 10, 2015
New assays use innovative Firefly particle technology to enhance miRNA research.
Multiplicom Expands its Gene Panels for Breast and Ovarian Cancers
Tuesday, June 09, 2015
Company has released two novel kits: the BRCA Hereditary Cancer and the BRCA Tumor MASTR™ Plus kit.
Agilent Releases New Target-Enrichment Solutions for Disease Research
Friday, June 05, 2015
Products address current limitations of exome sequencing.
New Single-Cell T-cell Receptor Assay
Wednesday, June 03, 2015
New assay for immunology and immuno-oncology research available from Cellular Research.
Kapa Biosystems Launches New RNA Prep Kit to Maximize Sequencing Efficiency
Tuesday, May 19, 2015
Ribodepletion kit boosts NGS throughput and data quality for more comprehensive view of transcriptome.
First Proton Treatments with RayStation and MEVION S250
Tuesday, May 12, 2015
Ackerman Cancer Center in Jacksonville, Florida treats its first patient with the MEVION S250 and the RayStation® Treatment Planning System.
Showing Results 41 - 50 of 735
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
Viral Gene Editing System Corrects Genetic Liver Disease
Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Curing Disease by Repairing Faulty Genes
New delivery method boosts efficiency of CRISPR genome-editing system.
'Junk' DNA Plays Role in Preventing Breast Cancer
Supposed "junk" DNA, found in between genes, plays a role in suppressing cancer, according to new research by Universities of Bath and Cambridge.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,900+ scientific and medical posters
4,200+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!